POSTERIOR CAPSULOTOMY CYSTITOME— 510(k) K840660
Substantially EquivalentSharpoint, Inc.
FDA 510(k) clearance K840660 for POSTERIOR CAPSULOTOMY CYSTITOME, Substantially Equivalent on 1984-03-16. Applicant: Sharpoint, Inc.. Device class: 1.
Clearance details
- Applicant
- Sharpoint, Inc.
- Product code
- Code HNY
- Device class
- Class 1
- Regulation
- 21 CFR 886.4350
- Advisory panel
- Ophthalmic
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Recent devices under product code HNY
view allMore clearances from Sharpoint, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.